Hart–Scott–Rodino Antitrust Improvements Act

The Czechoslovak Group Highlights the Benefits of Its Planned Acquisition of Vista Outdoor’s Sporting Products Business, The Kinetic Group

Retrieved on: 
Monday, April 8, 2024
Defense, Aerospace, Manufacturing, Military, Government Technology, Other Defense, Contracts, Kinetic, Firearm, Vista Outdoor, Growth, CFIUS, Czechoslovak Group, JPMorgan Chase, Committee, Acquisition, CCI, Foreign investment, Kinetic Group, Fiocchi Munizioni, Plant, CSG, Hart–Scott–Rodino Antitrust Improvements Act, Federal, Federal Trade Commission

CSG also highlighted the benefits of its planned Acquisition:

Key Points: 
  • CSG also highlighted the benefits of its planned Acquisition:
    “CSG is a leading industrial technology company operating across strategic business segments including defense, aerospace, ammunition and mobility.
  • We look forward to successfully closing the Acquisition of The Kinetic Group and becoming the steward of such venerable American brands as Federal, CCI and Remington.
  • CSG understands the special importance to American consumers of the brands that are part of The Kinetic Group.
  • Working alongside Vista Outdoor, we are actively engaged in the process and believe we will secure all required approvals.

Sunoco LP and NuStar Energy L.P. Announce Expiration of Hart-Scott-Rodino Act Waiting Period

Retrieved on: 
Tuesday, April 9, 2024
Energy, Other Energy, Utilities, Oil, Gas, Transfer, SUN, NuStar Energy, Partnership, NuSTAR, Acquisition, Transport, Security (finance), Energy Transfer Partners, Hart–Scott–Rodino Antitrust Improvements Act, Sunoco, Central Time

Sunoco LP (NYSE: SUN) (“Sunoco” or “SUN”) and NuStar Energy L.P. (NYSE: NS) (“NuStar” or “NS”) today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the “HSR Act”), in connection with Sunoco’s pending acquisition of NuStar.

Key Points: 
  • Sunoco LP (NYSE: SUN) (“Sunoco” or “SUN”) and NuStar Energy L.P. (NYSE: NS) (“NuStar” or “NS”) today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the “HSR Act”), in connection with Sunoco’s pending acquisition of NuStar.
  • The expiration of the waiting period under the HSR Act satisfies an important condition necessary for the completion of the transaction.
  • A NuStar unitholder vote is scheduled for May 1, 2024 at 9:00 am Central Time.
  • NuStar unitholders are anticipated to receive Sunoco’s distributions for the first quarter of 2024 following the closing of the transaction.

Hilton to Accelerate Expansion in Fast-Growing Lifestyle Category with Addition of Graduate Hotels to Global Brand Portfolio

Retrieved on: 
Thursday, March 14, 2024
Luxury, Vacation, Other Travel, Lodging, Commercial Building & Real Estate, Destinations, University, Construction & Property, Travel, Education, Retail, REIT, Hart–Scott–Rodino Antitrust Improvements Act, State College, Pennsylvania, Growth, Partnership, HLT, Acquisition, Tempo, Collection, Graduate Hotels, Curio (brand), Point, Multimedia, AJ, Hotel

“Adding Graduate Hotels to our portfolio of award-winning brands accelerates our expansion in the lifestyle space by pairing an existing much-loved brand with the power of Hilton’s strong commercial engine to drive growth,” said Chris Nassetta, president and CEO, Hilton.

Key Points: 
  • “Adding Graduate Hotels to our portfolio of award-winning brands accelerates our expansion in the lifestyle space by pairing an existing much-loved brand with the power of Hilton’s strong commercial engine to drive growth,” said Chris Nassetta, president and CEO, Hilton.
  • “We're proud to embark on this new chapter for Graduate Hotels with Hilton, the ideal partner to steer the brand's continued growth," said Ben Weprin, founder, Graduate Hotels and CEO, AJ Capital.
  • "Both Hilton and Graduate Hotels are committed to delivering exceptional experiences and making a positive impact on communities.
  • Our shared values and close collaboration will ensure a smooth transition while keeping the Graduate Hotels' unique brand identity intact.

Gilead Sciences Announces Expiration of Hart-Scott-Rodino Waiting Period for CymaBay Tender Offer

Retrieved on: 
Monday, March 11, 2024
Biotechnology, Hospitals, Pharmaceutical, Health, Science, Justice, Therapy, Hart–Scott–Rodino Antitrust Improvements Act, Eastern Time Zone, HSR, Federal Trade Commission

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) with respect to Gilead’s cash tender offer for CymaBay Therapeutics, Inc. expired at 11:59 p.m. on March 8, 2024.

Key Points: 
  • Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) with respect to Gilead’s cash tender offer for CymaBay Therapeutics, Inc. expired at 11:59 p.m. on March 8, 2024.
  • On February 22, 2024, Gilead and CymaBay filed the Premerger Notification and Report Forms required under the HSR Act with the Federal Trade Commission and the Antitrust Division of the U.S. Department of Justice.
  • The expiration of the HSR waiting period satisfies one of the conditions to consummate the tender offer.
  • Unless the tender offer is extended, the offer and withdrawal rights will expire at one minute after 11:59 p.m., Eastern Time, on March 21, 2024.

APA Corporation Announces Timeline For Closing of Callon Petroleum Company Transaction; Issues Investor Slide Deck Highlighting Top-Tier Permian Performance

Retrieved on: 
Monday, February 26, 2024
Permian, Acquisition, Data collection, Hart–Scott–Rodino Antitrust Improvements Act, APA Corporation, APA, Oil

Assuming both APA and Callon shareholder approvals are obtained, the closing of the acquisition is expected to occur on or about April 1, 2024.

Key Points: 
  • Assuming both APA and Callon shareholder approvals are obtained, the closing of the acquisition is expected to occur on or about April 1, 2024.
  • APA and Callon have scheduled separate shareholder meetings for March 27, 2024, for their respective shareholders to vote on the transaction.
  • We look forward to integrating the Callon assets and providing more information about the Permian Basin outlook from the combined assets.
  • The APA subsidiary Apache Corporation operates the majority of the company’s assets in the Permian Basin.

Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Recent Corporate Developments

Retrieved on: 
Wednesday, February 28, 2024
Health, Genetics, Research, Pharmaceutical, Science, Biotechnology, SRPT, Hart–Scott–Rodino Antitrust Improvements Act, Investment, Interest, Sarepta Therapeutics, Part, Sale, University, Trial of the century, Ageing, BLA, GAAP, Therapy, BioMarin Pharmaceutical, Income tax, PMR, Depreciation, Magnesium deficiency, Nationwide Children's Hospital, Hospital, Safety, Patent, Clinical trial, Biologics license application, Mutation, Priority review, Acquisition, PIN, Dystrophin, FDA, Food, DMD, Duchenne muscular dystrophy, U.S. FDA, Agency, Patient, PRV, PMO, Pharmaceutical industry

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported financial results for the fourth quarter and full-year 2023.

Key Points: 
  • Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported financial results for the fourth quarter and full-year 2023.
  • Beginning in the fourth quarter of 2023, amortization of in-licensed rights (formerly included within depreciation and amortization expense) and income tax (benefit) expense are no longer excluded from the non-GAAP results.
  • Non-GAAP financial results for the fourth quarter and full-year 2022 have been updated to reflect this change for comparability.
  • All relevant non-GAAP measures are reconciled from their respective GAAP measures in the attached table “Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures.”

Pembina Pipeline Corporation Reports Record Results for the Fourth Quarter 2023, Provides Business Update, and Declares Quarterly Common Share Dividend

Retrieved on: 
Thursday, February 22, 2024
Energy, Other Energy, Utilities, Oil, Gas, Transfer, Momentum, Carbon, Engineering, Conversation, Weather, ACG, Web browser, RFS, TC Energy, Growth, Montney, British Columbia, LNG Canada, Pipeline, WCSB, Sale, E6, Season, Tax, EPC, Corporation, Peace, Emperor, Marketing, Black & Veatch, Management, Propane, Transport, Phase, Depreciation, Partnership, Hart–Scott–Rodino Antitrust Improvements Act, BBB, Natural gas, Alliance Pipeline, Elk, Black, FID, Dow, Insurance, Hydrocarbon, Acquisition, Wildfire, Mountain Valley Pipeline, Ethane, NEBC, Ruby, NGL, Coastal GasLink Pipeline, Facility, Younger, PGI

Pembina reported record quarterly adjusted EBITDA of $1,033 million in the fourth quarter and record full year adjusted EBITDA of $3,824 million.

Key Points: 
  • Pembina reported record quarterly adjusted EBITDA of $1,033 million in the fourth quarter and record full year adjusted EBITDA of $3,824 million.
  • Results were impacted by higher incentive costs driven by Pembina's share price performance and increased shared service revenue.
  • On a per share (basic) basis, cash flow from operating activities was $1.60 per share for the fourth quarter and $4.79 per share for the full year.
  • ET) for interested investors, analysts, brokers and media representatives to discuss results for the fourth quarter of 2023.

CenterPoint Energy announces sale of its Louisiana and Mississippi natural gas assets to Bernhard Capital Partners for $1.2 billion

Retrieved on: 
Tuesday, February 20, 2024
Energy, Utilities, Oil, Gas, CenterPoint Energy, Natural gas, Growth, Sale, Wells Fargo, Safety, PLLC, Hart–Scott–Rodino Antitrust Improvements Act, Public expenditure, LDC, CNP, EPS, Renewable energy

CenterPoint Energy, Inc. (NYSE: CNP) (“CenterPoint”) today announced the sale of its Louisiana and Mississippi natural gas LDC businesses to Bernhard Capital Partners, a services and infrastructure-focused private equity management firm, for $1.2 billion.

Key Points: 
  • CenterPoint Energy, Inc. (NYSE: CNP) (“CenterPoint”) today announced the sale of its Louisiana and Mississippi natural gas LDC businesses to Bernhard Capital Partners, a services and infrastructure-focused private equity management firm, for $1.2 billion.
  • The assets include approximately 12,000 miles of main pipeline in Louisiana and Mississippi serving approximately 380,000 metered customers.
  • CenterPoint’s LDCs are the second largest natural gas LDCs in both Louisiana and Mississippi by customer accounts, with a combined workforce of approximately 550 employees.
  • The sales price of $1.2 billion represents approximately 32 multiple of 2023 Louisiana and Mississippi LDC earnings.

Bristol Myers Squibb and RayzeBio Announce Expiration of HSR Act Waiting Period

Retrieved on: 
Monday, February 12, 2024
Biotechnology, Health, Pharmaceutical, Clinical Trials, Oncology, Bristol Myers Squibb, BMY, EST, Hart–Scott–Rodino Antitrust Improvements Act, Multimedia

Bristol Myers Squibb (NYSE: BMY) and RayzeBio, Inc. (Nasdaq: RYZB) today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, or HSR Act, in connection with Bristol Myers Squibb’s previously announced tender offer to acquire all of the outstanding shares of RayzeBio common stock for a purchase price of $62.50 per share in cash, or approximately $4.1 billion.

Key Points: 
  • Bristol Myers Squibb (NYSE: BMY) and RayzeBio, Inc. (Nasdaq: RYZB) today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, or HSR Act, in connection with Bristol Myers Squibb’s previously announced tender offer to acquire all of the outstanding shares of RayzeBio common stock for a purchase price of $62.50 per share in cash, or approximately $4.1 billion.
  • The expiration of the waiting period occurred at 11:59 p.m. EST on February 9, 2024.
  • View the full release here: https://www.businesswire.com/news/home/20240211117969/en/
    Expiration of the waiting period under the HSR Act satisfies one of the conditions necessary for the consummation of the transaction, including the tender offer and the merger, which remains subject to the tender of a majority of the outstanding shares of RayzeBio’s common stock, as well as other customary closing conditions.
  • Unless the tender offer is extended, the offer will expire one minute after 11:59 p.m. New York City time, on February 22, 2024.

Diamondback Energy, Inc. and Endeavor Energy Resources, L.P. to Merge to Create a Premier Permian Independent Oil and Gas Company

Retrieved on: 
Monday, February 12, 2024
Permian, Hart–Scott–Rodino Antitrust Improvements Act, Jefferies Group, FANG, Capital market, Vinson & Elkins, Culture, Growth, Diamondback Energy, Safety, Standstill, Webcast, Citigroup, Security (finance), Goldman Sachs, Hand, Logic, MBO, Management

The combination will create a premier Permian independent operator.

Key Points: 
  • The combination will create a premier Permian independent operator.
  • The transaction consideration will consist of approximately 117.3 million shares of Diamondback common stock and $8 billion of cash, subject to customary adjustments.
  • The transaction was unanimously approved by the Board of Directors of the Company and has all necessary Endeavor approvals.
  • “This is a combination of two strong, established companies merging to create a ‘must own’ North American independent oil company.